Edition:
United Kingdom

Glaukos Corp (GKOS.N)

GKOS.N on New York Stock Exchange

28.54USD
19 Jan 2018
Change (% chg)

$-0.01 (-0.04%)
Prev Close
$28.55
Open
$28.65
Day's High
$28.71
Day's Low
$27.60
Volume
82,233
Avg. Vol
153,442
52-wk High
$52.41
52-wk Low
$23.10

Select another date:

Wed, Jan 10 2018

BRIEF-Glaukos' Idose Travoprost Achieves Sustained IOP Reduction And Favorable Safety Profile In 12-Month Interim Cohort

* GLAUKOS CORPORATION’S IDOSE™ TRAVOPROST ACHIEVES SUSTAINED IOP REDUCTION AND FAVORABLE SAFETY PROFILE IN 12-MONTH INTERIM COHORT

BRIEF-Glaukos Submits IDE Application To FDA To Study iStent Infinite Trabecular Micro-Bypass System

* GLAUKOS SUBMITS IDE APPLICATION TO FDA TO STUDY ISTENT INFINITE™ TRABECULAR MICRO-BYPASS SYSTEM

BRIEF-Glaukos Corp posts Q3 earnings per share $0.04

* Glaukos Corporation announces third quarter 2017 financial results

BRIEF-James Flynn reports a 7.34 pct passive stake in Glaukos

* James E. Flynn reports a 7.34 Pct passive stake in Glaukos Corp as of Sept 14 - SEC filing Source text: [http://bit.ly/2xBLsij] Further company coverage:

BRIEF-Glaukos Corporation Q2 loss per share $0.10

* Glaukos Corporation announces second quarter 2017 financial results

Select another date: